Linda C. Burkly - 25 Jul 2024 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Signature
/s/ Linda C. Burkly
Issuer symbol
EDIT
Transactions as of
25 Jul 2024
Net transactions value
-$64,370
Form type
4
Filing time
26 Jul 2024, 17:02:15 UTC
Previous filing
05 Mar 2024
Next filing
05 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale $64,370 -11,886 -14% $5.42 73,136 25 Jul 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2024. The sale does not represent a discretionary trade by the Reporting Person.